KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $253.5 billion.

  • Cvs Health's Liabilities and Shareholders Equity rose 12.76% to $253.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1022.8 billion, marking a year-over-year increase of 148.11%. This contributed to the annual value of $253.5 billion for FY2025, which is 12.76% up from last year.
  • Latest data reveals that Cvs Health reported Liabilities and Shareholders Equity of $253.5 billion as of Q4 2025, which was up 12.76% from $255.3 billion recorded in Q3 2025.
  • Cvs Health's 5-year Liabilities and Shareholders Equity high stood at $258.3 billion for Q2 2025, and its period low was $228.3 billion during Q4 2022.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $249.7 billion (2023), whereas its average is $243.6 billion.
  • As far as peak fluctuations go, Cvs Health's Liabilities and Shareholders Equity crashed by 202.75% in 2022, and later skyrocketed by 939.79% in 2023.
  • Over the past 5 years, Cvs Health's Liabilities and Shareholders Equity (Quarter) stood at $233.0 billion in 2021, then fell by 2.03% to $228.3 billion in 2022, then grew by 9.4% to $249.7 billion in 2023, then grew by 1.4% to $253.2 billion in 2024, then grew by 0.13% to $253.5 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $253.5 billion for Q4 2025, versus $255.3 billion for Q3 2025 and $258.3 billion for Q2 2025.